S065 Great Care for Common Conditions: Combining Evidence and Cost Effectiveness
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
"This session will examine the data and provide an evidenced based discussion about best cost effective practices to care for patients with photoaging, acne, psoriasis, HS, as well as hair and nail disease.
This session will provide an opportunity to review and apply some time-honored strategies, as well as a few new ones, to the factors that make our lives feel out of control. This activity has been approved by the American Board of Dermatology (ABD) for up to 30 Continuous Certification Program (CCP) Component 2 Self-Assessment points. For more information about CCP, please visit the ABD website at www.abderm.org"
LEARNING OBJECTIVES
Assess cost effective care of various skin diseases and conditions including photoaging, acne, hair and nail disease, among others.
Examine evidence that drives decision making for skin disease such as psoriasis and HS.
SCHEDULE
5:00 PM
Introduction
Scott Elman, MD, FAAD
5:05 PM
Evidenced based care of alopecia areata
Arash Mostaghimi, MD, MPH, FAAD
5:35 PM
Evidenced based care of CTCL
Xiaolong Alan Zhou, MD, MSc, FAAD
6:05 PM
Evidenced based care of psoriasis
Zenas Yiu, MBChB, PhD, MSc, IFAAD
6:35 PM
Evidenced based care of acne
Jonette Elizabeth Keri, MD, PhD, FAAD
7:05 PM
Evidenced base care of photoaging
Shasa Hu, MD, FAAD
7:35 PM
Evidenced base care of urticaria
Scott Elman, MD, FAAD
SPEAKERS
Scott Elman, MD, FAAD
Shasa Hu, MD, FAAD
Jonette Elizabeth Keri, MD, PhD, FAAD
Arash Mostaghimi, MD, MPH, FAAD
Zenas Yiu, MBChB, PhD, MSc, IFAAD
Xiaolong Alan Zhou, MD, MSc, FAAD
HANDOUTS
SPEAKER DISCLOSURES
Scott Elman, MD, FAAD
Biogen – Consultant(Fees); Bristol Myers Squibb – Investigator(Grants/Research Funding); EMD Serono – Consultant (1099 relationship)(Fees); Pfizer Inc. – Investigator(Grants/Research Funding);
Shasa Hu, MD, FAAD
BPG bio – Consultant (1099 relationship)(Honoraria); L'Oreal USA Inc. – Consultant(Honoraria); Swiss American – Consultant(Honoraria);
Jonette Elizabeth Keri, MD, PhD, FAAD
Almirall – Consultant(Fees); Galderma Mexico – Speaker(Honoraria); Galderma USA – Investigator(Grants/Research Funding); L'Oreal – Advisory Board(Honoraria); Ortho Dermatologics – Advisory Board(Honoraria); Primus Pharmaceuticals – Advisory Board(Honoraria); Sanofi – Advisory Board(Honoraria);
Arash Mostaghimi, MD, MPH, FAAD
AbbVie – Consultant(Fees); ACOM – Consultant (1099 relationship)(Fees); Boehringer Ingelheim – Consultant (1099 relationship)(Fees), Speaker(Fees); Digital Diagnostics – Consultant(Fees); Eli Lilly and Company – Advisory Board(Fees), Investigator(Grants/Research Funding); Equillium, Inc. – Consultant(Fees); Figure 1 Beauty, Inc. – Advisory Board(Stock); hims – Advisory Board(Stock); Incyte Corporation – Investigator(Grants/Research Funding); Olaplex – Advisory Board(Fees); Pelage Pharmaceuticals – Advisory Board(Fees); Pfizer Inc. – Advisory Board(Fees), Consultant(Fees); Sun Pharmaceutical Industries Ltd. – Advisory Board(Fees);
Zenas Yiu, MBChB, PhD, MSc, IFAAD
No financial relationships exist with ineligible companies.
Xiaolong Alan Zhou, MD, MSc, FAAD
Kyowa Kirin – Consultant (1099 relationship)(Fees);